The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with ClinVar but not with the Allele Registry data


Variant: NM_000215.4(JAK3):c.1796T>G (p.Val599Gly)

624608 (ClinVar)

Gene: JAK3
Condition: T-B+ severe combined immunodeficiency due to JAK3 deficiency
Inheritance Mode: Autosomal recessive inheritance
UUID: f0ce65af-4ee6-412b-a75d-8b5147663418

HGVS expressions

NM_000215.4:c.1796T>G
NM_000215.4(JAK3):c.1796T>G (p.Val599Gly)

Uncertain Significance

Met criteria codes 2
PP4_Moderate PM2_Supporting
Not Met criteria codes 1
PM3

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Severe Combined Immunodeficiency Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for JAK3 Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Severe Combined Immunodeficiency Disease VCEP
The NM_000215.4(JAK3):c.1796T>G (p.Val599Gly) missense variant has been reported in a TlowB+NKlow patient (patient 4 of PMID: 30032486), diagnosed with leaky SCID (reported in PMID: 31456805), including low CD3+ cells (733.5 cells/ul), reduced, but detectable, proliferative response to PHA (>10 < 30% of the control), and absence of maternal engraftment. Patient cells also had defective STAT5 phosphorylation after IL2 or IL15 stimulation. This combination is highly specific for T-B+ severe combined immunodeficiency due to JAK3 deficiency (PP4). Patient 4 (PMID: 30032486) is compound heterozygous for p.V599G and p.W709R (Classified VUS by the SCID VCEP) confirmed in trans, but this co-occurrence of variants is insufficient for the PM3 criteria. This variant is absent from gnomAD v2.1.1 (PM2_Supporting). In summary, this variant meets the criteria to be classified as uncertain significance for autosomal recessive T-B+ SCID based on the ACMG/AMP criteria applied, as specified by the ClinGen SCID VCEP. Criteria applied: PM2_supporting, PP4. (VCEP specifications version 1).
Met criteria codes
PP4_Moderate
This variant was identified in at least one TlowB+NKlow (CD3+ 733.5 cells/ul, CD19+ 4,126.7 cells/ul, CD16+/CD56+ 70.0 cells/ul) patient (patient 4 of PMID: 30032486) by two different custom Ion Torrent panels for a total of 42 genes related to a broad spectrum of PID (0.5pt). The patient met diagnostic criteria for leaky SCID (reported in PMID: 31456805), including CD3+ 733.5 cells/ul and reduced, but detectable, proliferative response to PHA (> 10 < 30% of the control), plus absence of maternal engraftment (0.5pt) and had defective STAT5 phosphorylation after IL2 or IL15 stimulation (1pt). This combination is highly specific for T-B+ severe combined immunodeficiency due to JAK3 deficiency (Total 2pt; PP4_moderate).
PM2_Supporting
This variant is absent from gnomAD v2.1.1 (PM2_Supporting).
Not Met criteria codes
PM3
Pt 4 (first reported in PMID: 30032486) is compound heterozygous for p.V599G and p.W709R (classified VUS by SCID VCEP), confirmed in trans (0.25pt; PM3_NotMet).
Approved on: 2024-01-17
Published on: 2024-01-17
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.